A note from our Chair 

2021-22 has been pivotal for the AHSNs and the AHSN Network. While we are still supporting our health and care systems with the recovery from the pandemic, we have undertaken work to set out our vision and strategy and refine our processes to ensure we can meet our collective ambition to transform as many lives as possible through more rapid uptake of high value innovation in health and care.

This report reflects our national AHSN Network priorities and our impacts within these areas of work.

I’d like to thank all my colleagues from across the Network and our partners for their continued support this year. We know that team working is key to health system transformation and our achievements are only possible together.

Professor Gary Ford CBE, FMedSci
Chair of the AHSN Network and Chief Executive of Oxford AHSN

Image: cover of the AHSN Network impact report 21-22

 

 

 

 

 

 

Read the Impact Report PDF. You can see more impact stories on the pages below.

2021/22 impacts

Illustration. Text reads: More than 480,000 patients benefited from our national programmes and initiatives. 1,273 innovations in our national pipeline of innovation. £455 investment leveraged by companies supported by AHSNs.

  • Meet the innovator: Angie Doshani

    Meet the innovator: Angie Doshani

    Angie Doshani, is founder of JanamApp and Consultant Obstetrician and Gynaecologist at University Hospitals of Leicester NHS Trust. JanamApp is a ground-breaking solution addressing the disparities in pregnancy outcomes faced by South Asian women, who experience a 1.8 times higher risk compared to their white counterparts. The challenges of some women from this demographic include [...]

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]